Schizophrenia Research 2006: Vol 82 Index & Table of Contents

2006·2.3 MB·English

Available online at www.sciencedirect.com
SCHIZOPHRENIA
science @oinecr:
RESEARCH
A ei
ELSEVIER
Schizophrenia Research 82 (2006) 287-289
www.elsevier.com/locate/schres
Author index to volume 82
Artiges, E., Martelli, C., Naccache, L., Bartrés-Faz, D., LeProvost, David, A.S., see Rossell, S.L., 121
J.-B., Viard, A., Paillere-Martinot, M.-L., Dehaene, S. and De Peri, L., see Vita, A., 75
Martinot, J.-L. Dehaene, S., see Artiges, E., 143
Paracingulate sulcus morphology and fMRI activation detection Dieci, M., see Vita, A., 75
in schizophrenia patients, 143 Diwadkar, V.A., see Girgis, R.R., 89
D’Souza, D.C., see Srihari, V.H., 261
Badcock, J.C., see Waters, F.A.V., 271 Dubinsky, T., see Ritsner, M.S., 39
Barton, J.J.S., see Polli, F-E., 191 Dwolatzky, T., see Ritsner, M.S., 39
Bartres-Faz, D., see Artiges, E., 143
Bedoya, G., see Miranda, A., 283 Eichhammer, P., see Sand, P., 277
Benedek, G., see Kéri, S., 9 Eisen, J.L., see Kaplan, G.B., 279
Bersani, G., Maneschi, M.L., Tarolla, E. and Pancheri, P. Epstein-Lubow, G., Hochstadt, J., Lieberman, P. and Kaplan, G.B.
Dyslexia as a possible aspect of neurocognitive impairment in Speech production in schizophrenia: Preliminary data regarding
schizophrenia, 265 voice onset time, 267
Birrell, C., see Van den Oord, E.J.C.G., 213
Blumenkrantz, H., see Ritsner, M.S., 39
Faulkner, G., Cohn, T. and Remington, G.
Bowden, N.A., Weidenhofer, J.. Scott, R.J., Schall, U., Todd, J.,
Validation of a physical activity assessment tool for individuals
Michie, P.T. and Tooney, P.A.
with schizophrenia, 225
Preliminary investigation of gene expression profiles in
Féron, F., see McCurdy, R.D., 163
peripheral blood lymphocytes in schizophrenia, 175
Buck, K.D., see Lysaker, P.H., 241
Garcia, J., see Miranda, A., 283
Bukszar, J., see Van den Oord, E.J.C.G., 213
Giegling, I., see Van den Oord, E.J.C.G., 213
Butler, P.D., see Kim, D., |
Girgis, R.R., Diwadkar, V.A., Nutche, J.J.. Sweeney, J.A.,
Byerly, M.J., see Nakonezny, P.A., 107
Keshavan, M.S. and Hardan, A.Y.
Risperidone in first-episode psychosis: A_ longitudinal,
Calle, J., see Miranda, A., 283
exploratory voxel-based morphometric study, 89
Campo, O., see Miranda, A., 283
Goff, D.C., see Holt, D.J., 153
Cardenio, C., see Miranda, A., 283
Goff, D.C., see Polli, F.E., 191
Ceskova, E., see Sand, P., 277
Goldenberg, J., see Reichenberg, A., 233
Chan, R.C.K., Chen, E.Y.H. and Law, C.W.
Gooding, D.C., Matts, C.W. and Rollmann, E.A.
Specific executive dysfunction in patients with first-episode
Sustained attention deficits in relation to psychometrically
medication-naive schizophrenia, 51
identified schizotypy: Evaluating a potential endophenotypic
Chant, D.C., see McCurdy, R.D., 163
marker, 27
Chen, E.Y.H., see Chan, R.C.K., 51
Gordon, D., see Miranda, A., 283
Claridge, G., see Mason, O., 203
Cohn, T., see Faulkner, G., 225
Covington, M.A. Hajak, G., see Sand, P., 277
Pronunciation of the z in schizophrenia, 275 Hammoud, K., see Lysaker, P.H., 241
Hardan, A.Y., see Girgis, R.R., 89
Davenport, N.D., Sponheim, S.R. and Stanwyck, J.J. Hayward, N.K., see McCurdy, R.D., 163
Neural anomalies during visual search in schizophrenia patients Heckers, S., see Holt, D.J., 153
and unaffected siblings of schizophrenia patients, 15 Hochstadt, J., see Epstein-Lubow, G., 267
0920-9964/$ - see front matter © 2005 Elsevier B.V. All rights reserved.
doi: 10.1016/S0920-9964(06)00047-8
288 Author index to volume 82
Holt, D.J., Kunkel, L., Weiss, A.P., Goff, D.C., Wright, C.1., Shin, MacAskill, H.S., see Kaplan, G.B., 279
L.M., Rauch, S.L., Hootnick, J. and Heckers, S. Mackay-Sim, A., see McCurdy, R.D., 163
Increased medial temporal lobe activation during the passive Mahadik, S.P., see Pillai, A., 95
viewing of emotional and neutral facial expressions in Maneschi, M.L., see Bersani, G., 265
schizophrenia, 153 Manoach, D.S., see Polli, F.E., 191
Hootnick, J., see Holt, D.J., 153 Martelli, C., see Artiges, E., 143
Martinot, J.-L., see Artiges, E., 143
Iguchi, L., see Polli, F.E., 191 Mason, O. and Claridge, G.
Ikeda, M., see Kishi, T., 185 The Oxford-Liverpool Inventory of Feelings and Experiences
Iwata, N., see Kishi, T., 185 (O-LIFE): Further description and extended norms, 203
Matigian, N., see McCurdy, R.D., 163
Janka, Z., see Kéri, S., 9 Matts, C.W., see Gooding, D.C., 27
Javitt, D.C., see Kim, D., | Mavreas, V., see Peritogiannis, V., 119
Jin Lee, K., see Kim, J., 65 Maybery, M.T., see Waters, F.A.V., 271
McCarley, R.W., see Nestor, P.G., 139
Kaplan, G.B., see Epstein-Lubow, G., 267 McCurdy, R.D., Feron, F., Perry, C., Chant, D.C., McLean, D.,
Kaplan, G.B., Phillips, K.A., Vaccaro, A., Eisen, J.L., Posternak, Matigian, N., Hayward, N.K., McGrath, J.J. and Mackay-Sim, A.
M.A., MacAskill, H.S. Cell cycle alterations in biopsied olfactory neuroepithelium in
Assessment of insight into delusional beliefs in schizophrenia schizophrenia and bipolar | disorder using cell culture and gene
using the Brown Assessment of Beliefs Scale, 279 expression analyses, 163
Kelemen, O., see Keri, S., 9 McGrath, J.J., see McCurdy, R.D., 163
Keri, S., Must, A., Kelemen, O., Benedek, G. and Janka, Z. McLean, D., see McCurdy, R.D., 163
Development of visual motion perception in children of patients Michie, P.T., see Bowden, N.A., 175
with schizophrenia and bipolar disorder: A follow-up study, 9 Middleton, L., see Van den Oord, E.J.C.G., 213
Keshavan, M.S., see Girgis, R.R., 89 Miranda, A., Garcia, J., Lopez, C., Gordon, D., Palacio, C.,
Kick, C., see Sand, P., 277 Restrepo, G., Ortiz, J.. Montoya, G., Cardefio, C., Calle, J.,
Kim, D., Wylie, G., Pasternak, R., Butler, P.D. and Javitt, D.C. Lopez, M., Campo, O., Bedoya, G., Ruiz-Linares, A. and
Magnocellular contributions to impaired motion processing in Ospina-Duque, J.
schizophrenia, | Putative association of the carboxy-terminal PDZ ligand of
Kim, J., Park, S., Shin, Y.-W., Jin Lee, K. and Soo Kwon, J. neuronal nitric oxide synthase gene (CAPON) with schizo-
Self-initiated encoding facilitates object working memory in phrenia in a Colombian population, 283
schizophrenia: Implications for the etiology of working memory Moller, H.-J., see Van den Oord, E.J.C.G., 213
deficit, 65 Montoya, G., see Miranda, A., 283
Kim, J.H., Yim, S.J. and Nam, J.H. Muglia, P., see Van den Oord, E.J.C.G., 213
A 12-week, randomized, open-label, parallel-group trial of Murrelle, L., see Van den Oord, E.J.C.G., 213
topiramate in limiting weight gain during olanzapine treatment Must, A., see Keri, S., 9
in patients with schizophrenia, 115
Kinoshita, Y., see Kishi, T., 185 Naccache, L., see Artiges, E., 143
Kishi, T., Ikeda, M., Suzuki, T., Kitajima, T., Yamanouchi, Y., Nakonezny, P.A. and Byerly, M.J.
Kinoshita, Y., Ozaki, N. and Iwata, N. Electronically monitored adherence in outpatients with
No association of complexin! and complexin2 genes with schizophrenia or schizoaffective disorder: A comparison of
schizophrenia in a Japanese population, 185 first- vs. second-generation antipsychotics, 107
Kitajima, T., see Kishi, T., 185 Nam, J.H., see Kim, J.H., 115
Kucerova, H., see Sand, P., 277 Nestor, P.G., Valdman, O., Niznikiewicz, M., Spencer, K.,
Kunkel, L., see Holt, D.J., 153 McCarley, R.W. and Shenton, M.E.
Word priming in schizophrenia: Associational and semantic
Langguth, B., see Sand, P., 277 influences, 139
Law, C.W., see Chan, R.C.K., 51 Niznikiewicz, M., see Nestor, P.G., 139
Lee, T.-S.W., see Srihari, V.H., 261 Nutche, J.J., see Girgis, R.R., 89
LeProvost, J.-B., see Artiges, E., 143
Lieberman, P., see Epstein-Lubow, G., 267 Ortiz, J., see Miranda, A., 283
Lopez, C., see Miranda, A., 283 Ospina-Duque, J., see Miranda, A., 283
Lopez, M., see Miranda, A., 283 Ozaki, N., see Kishi, T., 185
Lysaker, P.H., Buck, K.D., Hammoud, K., Taylor, A.C. and Roe, D.
Associations of symptoms, psychosocial function and hope with Paillere-Martinot, M.-L., see Artiges, E., 143
qualities of self-experience in schizophrenia: Comparisons of Palacio, C., see Miranda, A., 283
objective and subjective indicators of health, 241 Pancheri, P., see Bersani, G., 265
Author index to volume 82
Pappas, D., see Peritogiannis, V., 119 Shin, L.M., see Holt, D.J., 153
Park, S., see Kim, J., 65 Shin, Y.-W., see Kim, J., 65
Pasternak, R., see Kim, D., | Silenzi, C., see Vita, A., 75
Peritogiannis, V., Tsouli, S., Pappas, D. and Mavreas, V. Soo Kwon, J., see Kim, J., 65
Corrigendum to “Acute effects of clozapine—fluvoxamine Spencer, K., see Nestor, P.G., 139
combination” [Schizophr. Res. 79 (2—3) (2005) 345-346], 119 Sponheim, S.R., see Davenport, N.D., 15
Perna, M., see Sand, P., 277 Srihari, V.H., Lee, T.-S.W., Rohrbaugh, R.M. and D’Souza, D.C.
Perry, C., see McCurdy, R.D., 163 Revisiting cycloid psychosis: A case of an acute, transient and
Phillips, K.A., see Kaplan, G.B., 279 recurring psychotic disorder, 261
Pillai, A., Terry Jr., A.V. and Mahadik, S.P. Stanwyck, J.J., see Davenport, N.D., 15
Differential effects of long-term treatment with typical and Stoertebecker, P., see Sand, P., 277
atypical antipsychotics on NGF and BDNF levels in rat striatum Suzuki, T., see Kishi, T., 185
and hippocampus, 95 Sweeney, J.A., see Girgis, R.R., 89
Polli, F.E., Barton, J.J.S., Vangel, M., Goff, D.C., Iguchi, L. and
Manoach, D.S. Tarolla, E., see Bersani, G., 265
Schizophrenia patients show intact immediate error-related Taylor, A.C., see Lysaker, P.H., 241
performance adjustments on an antisaccade task, 191 Terry Jr., A.V., see Pillai, A., 95
Posternak, M.A., see Kaplan, G.B., 279 Todd, J., see Bowden, N.A., 175
Prikryl, R., see Sand, P., 277 Tooney, P.A., see Bowden, N.A., 175
Tsouli, S., see Peritogiannis, V., 119
Rauch, S.L., see Holt, D.J., 153
Reichenberg, A. and Goldenberg, J. Vaccaro, A., see Kaplan, G.B., 279
Self-reported mental health difficulties and subsequent risk for Valdman, O., see Nestor, P.G., 139
schizophrenia in females: A 5-year follow-up cohort study, 233 Van den Oord, E.J.C.G., Rujescu, D., Robles, J.R., Giegling, L.,
Remington, G., see Faulkner, G., 225 Birrell, C., Bukszar, J., Murrelle, L., Miller, H.-J., Middleton, L.
Restrepo, G., see Miranda, A., 283 and Muglia, P.
Ritsner, M.S., Blumenkrantz, H., Dubinsky, T. and Dwolatzky, T. Factor structure and external validity of the PANSS revisited,
The detection of neurocognitive decline in schizophrenia using 213
the Mindstreams Computerized Cognitive Test Battery, 39 Vangel, M., see Polli, F.E., 191
Robles, J.R., see Van den Oord, E.J.C.G., 213 Viard, A., see Artiges, E., 143
Roe, D., see Lysaker, P.H., 241 Vita, A., De Peri, L., Silenzi, C. and Dieci, M.
Rohrbaugh, R.M., see Srihari, V.H., 261 Brain morphology in first-episode schizophrenia: A meta-
Rollmann, E.A., see Gooding, D.C., 27 analysis of quantitative magnetic resonance imaging studies,
Rossell, S.L. and David, A.S. 75
Are semantic deficits in schizophrenia due to problems with
access or storage?, 121 Waters, F.A.V., Badcock, J.C. and Maybery, M.T.
Rossell, S.L. The ‘who’ and ‘when’ of context memory: Different patterns of
Category fluency performance in patients with schizophrenia association with auditory hallucinations, 271
and bipolar disorder: The influence of affective categories, 135 Weidenhofer, J., see Bowden, N.A., 175
Ruiz-Linares, A., see Miranda, A., 283 Weiss, A.P., see Holt, D.J., 153
Rujescu, D., see Van den Oord, E.J.C.G., 213 Winkelman, J.W., see Yang, C., 251
Wright, C.1., see Holt, D.J., 153
Sand, P., Langguth, B., Hajak, G., Perna, M., Prikryl, R., Kucerova, Wylie, G., see Kim, D., |
H., Ceskova, E., Kick, C., Stoertebecker, P. and Eichhammer, P.
Screening for Neuroligin 4 (NLGN4) truncating and trans- Yamanouchi, Y., see Kishi, T., 185
membrane domain mutations in schizophrenia, 277 Yang, C. and Winkelman, J.W.
Schall, U., see Bowden, N.A., 175 Clinical significance of sleep EEG abnormalities in chronic
Scott, R.J., see Bowden, N.A., 175 schizophrenia, 251
Shenton, M.E., see Nestor, P.G., 139 Yim, S.J., see Kim, J.H., 115

Ape TR Le Bi, Available online at www.sciencedirect.com
SCHIZOPHRENIA
SCIENCE @erscer-
” RESEARCH
ELSEVIER
Schizophrenia Research 82 (2006) 291 —295
www.elsevier.com/locate/schres
Subject index to volume 82
Access Attention
Semantic; Schizophrenia; Storage 121 Schizophrenia; Working memory; Encoding; Remediation;
Neurocognition 65
Affect
Fluency; Semantic; Phonological; Schizophrenia; Bipolar Atypical antipsychotics
disorder 135 Risperidone; Voxel-based morphometry; First-episode psycho-
sis; Neuroplasticity 89
Affective disorders
Prodrome; Schizophrenia; Psychological distress 233
BDNF
Antipsychotics; Brain; NGF = 95
Age
Schizophrenia; Classification; Peripheral blood lymphocytes;
Bipolar disorder
Gene expression; Microarrays 175
Schizophrenia; Neurodevelopment; Motion perception 9
Amygdala
Schizophrenia; Functional magnetic resonance imaging: Bipolar disorder
Hippocampus; Emotion; Face 153 Fluency; Semantic; Phonological; Schizophrenia; Affect 135
Antipsychotic medication adherence Bipolar I disorder
Medication adherence; Schizophrenia —_107
Schizophrenia; Olfactory epithelium; Neurogenesis; Microarray;
Neurodevelopment 163
Antipsychotics
Brain; NGF; BDNF 95
Brain
Antipsychotics; NGF; BDNF = 95
Antisaccade task
Error processing; Performance monitoring; Inhibition; Post-
error slowing; Self-monitoring 191 Brain morphology
Schizophrenia; First-episode; Magnetic resonance imaging;
Meta-analysis 75
Associational bias
Schizophrenia; Priming; Thought disorder 139
Case report
Cycloid psychosis; Transient psychotic disorders; Schizophrenia;
Attention
Psychosis; Catatonia 261
Schizophrenia; Genetics; P300; Endophenotype; Serial search
15
Catatonia
Attention Cycloid psychosis; Transient psychotic disorders; Case report;
Schizotypy; Endophenotype; Continuous performance test 27 Schizophrenia; Psychosis 261
0920-9964/$ - see front matter © 2005 Elsevier B.V. All rights reserved.
doi: 10.1016/S0920-9964(06)00048-X
292 Subject index to volume 82
Cingulate Factor analysis
Schizophrenia; Functional MRI; Paracingulate sulcus; Schizophrenia; Positive and negative syndrome scale; External
Gyrification 143 validity 213
Classification First-episode
Schizophrenia; Peripheral blood lymphocytes; Gene expression; Schizophrenia; Brain morphology; Magnetic resonance imaging;
Microarrays; Age 175 Meta-analysis 75
Cognitive impairment First-episode psychosis
Sleep EEG; SWS deficit; Schizophrenia 251 Risperidone; Atypical antipsychotics; Voxel-based morphome-
try; Neuroplasticity 89
Complexin
Schizophrenia; Linkage disequilibrium; Haplotype-tagging First-episode schizophrenia
SNP 185 Executive function; Supervisory attention system 51
Continuous performance test Fluency
Schizotypy; Attention; Endophenotype 27 Semantic; Phonological; Schizophrenia; Bipolar disorder;
Affect 135
Cycloid psychosis
Transient psychotic disorders; Case report; Schizophrenia; Functional magnetic resonance imaging
Psychosis; Catatonia 261 Schizophrenia; Amygdala; Hippocampus; Emotion; Face ——-153
Emotion Functional MRI
Schizophrenia; Functional magnetic resonance imaging; Amyg- Schizophrenia; Paracingulate sulcus; Cingulate; Gyrifica-
dala; Hippocampus; Face _—_—‘153 tion 143
Encoding Gene expression
Schizophrenia; Working memory; Attention; Remediation; Schizophrenia; Classification; Peripheral blood lymphocytes;
Neurocognition 65 Microarrays; Age 175
Endophenotype Genetics
Schizophrenia; Genetics; Attention; P300; Serial search — 15 Schizophrenia; Attention; P300; Endophenotype; Serial
search 15
Endophenotype
Schizotypy; Attention; Continuous performance test 27 Gyrification
Schizophrenia; Functional MRI; Paracingulate sulcus; Cingulate
143
Error processing
Performance monitoring; Inhibition; Post-error slowing; Self-
monitoring; Antisaccade task 191 Haplotype-tagging SNP
Schizophrenia; Complexin; Linkage disequilibrium —185
Executive function
Supervisory attention system; First-episode schizophrenia Hippocampus
51 Schizophrenia; Functional magnetic resonance imaging; Amyg-
dala; Emotion; Face 153
External validity
Schizophrenia; Factor analysis; Positive and negative syndrome Inhibition
scale 213 Error processing; Performance monitoring; Post-error slowing;
Self-monitoring; Antisaccade task 191
Face
Schizophrenia; Functional magnetic resonance imaging; Amyg- Linkage disequilibrium
dala; Hippocampus; Emotion —__153 Schizophrenia; Complexin; Haplotype-tagging SNP ‘185
Subject index to volume 82
Magnetic resonance imaging Neuroplasticity
Schizophrenia; First-episode; Brain morphology; Meta-analysis Risperidone; Atypical antipsychotics; Voxel-based morphome-
75 try; First-episode psychosis 8&9
Magnocellular NGF
Schizophrenia; Motion; Visual; NMDA | Antipsychotics; Brain; BDNF 95
Measurement NMDA
Physical activity; Validation 225 Schizophrenia; Motion; Magnocellular; Visual |
Medication adherence Olfactory epithelium
Antipsychotic medication adherence; Schizophrenia —_-107 Schizophrenia; Bipolar | disorder; Neurogenesis; Microarray;
Neurodevelopment 163
Meta-analysis
Schizophrenia; First-episode; Brain morphology; Magnetic P300
resonance imaging 75 Schizophrenia; Genetics; Attention; Endophenotype; Serial
search 15
Microarray
Schizophrenia; Bipolar I disorder; Olfactory epithelium; Neuro- Paracingulate sulcus
genesis; Neurodevelopment 163 Schizophrenia; Functional MRI; Cingulate; Gyrification 143
Microarrays Performance monitoring
Schizophrenia; Classification; Peripheral blood lymphocytes; Error processing; Inhibition; Post-error slowing; Self-monitor-
Gene expression; Age 175 ing; Antisaccade task 191]
Peripheral blood lymphocytes
Mindstreams Computerized Cognitive Testing
Schizophrenia; Validity 39 Schizophrenia; Classification; Gene expression; Microarrays;
Age 175
Motion
Personality
Schizophrenia; Magnocellular; Visual; NUDA 1
Schizotypy 203
Motion perception
Phonological
Schizophrenia; Bipolar disorder; Neurodevelopment 9
Fluency; Semantic; Schizophrenia; Bipolar disorder; Affect
135
Narrative
Schizophrenia; Recovery; Symptoms; Remission 241
Physical activity
Measurement; Validation 225
Neurocognition
Schizophrenia; Working memory; Attention; Encoding;
Positive and negative syndrome scale
Remediation 65
Schizophrenia; Factor analysis; External validity 213
Neurodevelopment Post-error slowing
Schizophrenia; Bipolar disorder; Motion perception 9 Error processing; Performance monitoring; Inhibition; Self-
monitoring; Antisaccade task 191
Neurodevelopment
Schizophrenia; Bipolar I disorder; Olfactory epithelium; Neuro- Priming
genesis; Microarray 163 Schizophrenia; Associational bias; Thought disorder 139
Neurogenesis Prodrome
Schizophrenia; Bipolar I disorder; Olfactory epithelium; Micro- Schizophrenia; Affective disorders; Psychological distress
array; Neurodevelopment 163 233
294 Subject index to volume 82
Psychological distress Schizophrenia
Prodrome; Schizophrenia; Affective disorders 233 Priming; Associational bias; Thought disorder 139
Psychosis Schizophrenia
Cycloid psychosis; Transient psychotic disorders; Case report; Functional MRI; Paracingulate sulcus; Cingulate; Gyrifica-
Schizophrenia; Catatonia 261 tion 143
Recovery Schizophrenia
Schizophrenia; Symptoms; Narrative; Remission 241 Functional magnetic resonance imaging; Amygdala; Hippo-
campus; Emotion; Face 153
Remediation
Schizophrenia; Working memory; Attention; Encoding; Neuro- Schizophrenia
cognition 65 Bipolar I disorder; Olfactory epithelium; Neurogenesis; Micro-
array; Neurodevelopment 163
Remission
Schizophrenia; Recovery; Symptoms; Narrative 241 Schizophrenia
Classification; Peripheral blood lymphocytes; Gene expression;
Microarrays; Age —-1175
Risperidone
Atypical antipsychotics; Voxel-based morphometry; First-
episode psychosis; Neuroplasticity 89 Schizophrenia
Complexin; Linkage disequilibrium; Haplotype-tagging
SNP 185
Schizophrenia
Motion; Magnocellular; Visual; NMDA 1
Schizophrenia
Factor analysis; Positive and negative syndrome scale; External
Schizophrenia
validity 213
Bipolar disorder; Neurodevelopment; Motion perception 9
Schizophrenia Schizophrenia
Genetics; Attention; P300; Endophenotype; Serial search 15 Prodrome; Affective disorders; Psychological distress tNo >)w w
Schizophrenia Schizophrenia
Mindstreams Computerized Cognitive Testing; Validity 39 Recovery; Symptoms; Narrative; Remission 241
Schizophrenia Schizophrenia
Working memory; Attention; Encoding; Remediation; Neuro- Sleep EEG; SWS deficit; Cognitive impairment 2
an
cognition 65
Schizophrenia
Schizophrenia
Cycloid psychosis; Transient psychotic disorders; Case report;
First-episode; Brain morphology; Magnetic resonance imaging;
Psychosis; Catatonia 261
Meta-analysis 75
Schizotypy
Schizophrenia
Attention; Endophenotype; Continuous performance test 27
Antipsychotic medication adherence; Medication adherence
107
Schizotypy
Schizophrenia Personality 203
Semantic; Access; Storage 121
Self-monitoring
Schizophrenia Error processing; Performance monitoring; Inhibition; Post-
Fluency; Semantic; Phonological; Bipolar disorder, Affect error slowing; Antisaccade task 191
Subject index to volume 82
Semantic Thought disorder
Schizophrenia; Access; Storage 121 Schizophrenia; Priming; Associational bias —139
Semantic Transient psychotic disorders
Fluency; Phonological; Schizophrenia; Bipolar disorder; Affect Cycloid psychosis; Case report; Schizophrenia; Psychosis:
135 Catatonia 261
Serial search Validation
Schizophrenia; Genetics; Attention; P300; Endophenotype — ‘15 Physical activity; Measurement 225
Sleep EEG Validity
SWS deficit; Cognitive impairment; Schizophrenia 251 Mindstreams Computerized Cognitive Testing; Schizophrenia
39
Storage
Semantic; Schizophrenia; Access 121 Visual
Schizophrenia; Motion; Magnocellular; NMUDA |
Supervisory attention system
Executive function; First-episode schizophrenia 51
Voxel-based morphometry
Risperidone; Atypical antipsychotics; First-episode psychosis;
SWS deficit Neuroplasticity 89
Sleep EEG; Cognitive impairment; Schizophrenia 251
Working memory
Symptoms Schizophrenia; Attention; Encoding; Remediation; Neurocogni-
Schizophrenia; Recovery; Narrative; Remission 241 tion 65